Dr Nieusma: Deaths Accelerating, We Must Prepare & Protect our Loved Ones

Dr. Joe Nieusma returns to the program to share the latest on the depopulation and the death jab agenda. Unfortunately, it is becoming clear that deaths will continue to accelerate and the cause of death will continue to be deflected by the powers that be who control the mass media, the medical establishment and the political establishment. People must know there is hope if you prepare and protect your body from additional harm. You can contact Dr. Joe at SuperiorToxicology.com   See Important Proven Solutions to Keep Your from getting sick even if you had the mRNA Shot - Dr. Nieusma Learn more about the Nobel prize winning technology behind Govvi & how to save serious money on Gas: GOVVI.com/go/helpmesave See exclusive interviews on SarahWestall.TV or on Ebener (what is Ebener?)! Sign up at SarahWestall.com/Subscribe MUSIC CREDITS: "Cinematic Trailer" Media Music Group & "Do You Trust Me" by Michael Vignola, licensed for broad internet media use, including video and audio     See on Bastyon | Odysee | Bitchute | Rumble | SarahWestall.tv | Freedom.Social     Dr. Joe Nieusma Biography Dr. Joe Nieusma is our fearless CEO/Chief Toxicologist here at Superior Toxicology & Wellness, an international scientific consulting firm that he founded. Dr. Nieusma is also a co-founder for TwinOxide North America, a company working to improve water quality in all aspects of life from municipal treatment plants to livestock operations. TwinOxide removes all carcinogens from treated water and is the right thing to do. Dr. Nieusma is a member of the Scientific Advisory Board for Vitro Biopharma, a firm that brings new stem-cell related products for diabetes research to scientific, pharmaceutical, and ultimately medical markets.  Dr. Nieusma is also on the editorial staff for the peer-reviewed scientific journal, Toxicology Mechanisms and Methods, published by Informa Healthcare. Dr. Nieusma was a Senior Toxicologist for Affygility Solutions from October 2005 to February 2018. Affyg